{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:42:24Z","timestamp":1720507344820},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.drugpo.2016.05.014","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T10:42:58Z","timestamp":1464864178000},"page":"101-103","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014\u20132015"],"prefix":"10.1016","volume":"34","author":[{"given":"Michelle L.","family":"Nolan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennett","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary V.","family":"Kunins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Paone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.drugpo.2016.05.014_bib0005","first-page":"4","article-title":"Community drug early warning system (CDEWS) helps to identify emerging drugs at local level","volume":"33","author":"Artigiani","year":"2015","journal-title":"Justice Research and Statistics Association Forum"},{"issue":"1","key":"10.1016\/j.drugpo.2016.05.014_bib0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.drugalcdep.2014.07.009","article-title":"Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates","volume":"143","author":"Bonar","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2016.05.014_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/03602532.2013.839700","article-title":"The K2\/Spice phenomenon: Emergence, identification, legislation, and metabolic characterization of synthetic cannabinoids in herbal incense products","volume":"46","author":"Brents","year":"2014","journal-title":"Drug Metabolism Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2016.05.014_bib0020","first-page":"164","article-title":"The highs of tomorrow: Why new laws and policies are needed to meet the unique challenges of synthetic drugs","volume":"27","author":"Cohen","year":"2014","journal-title":"Journal of Law and Health"},{"issue":"1","key":"10.1016\/j.drugpo.2016.05.014_bib0025","first-page":"53","article-title":"Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs","volume":"26","author":"Gurney","year":"2014","journal-title":"Forensic Science Review"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0030","series-title":"Monitoring the Future national survey results on drug use, 1975\u20132014: Volume 2, college students and adults ages 19\u201355","author":"Johnson","year":"2015"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0035","series-title":"Mar. Stat. \u00a7\u00a7 6-119","article-title":"Maryland Parole and Probation\u2014Sanctioning Prohibited\u2014Citation","year":"2015"},{"issue":"5","key":"10.1016\/j.drugpo.2016.05.014_bib0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.drugpo.2014.11.013","article-title":"Query and test for synthetic cannabinoids in drug treatment and research","volume":"26","author":"Ninnemann","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0045","series-title":"Imposing penalties for the manufacture, distribution, or sale of synthetic cannabinoids and synthetic phenethylamines","author":"New York City Council","year":"2015"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0050","series-title":"Increase in synthetic cannabinoid-related adverse events and emergency department visits, New York City","author":"New York City Department of Health and Mental Hygiene","year":"2014"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0055","series-title":"Increase in synthetic cannabinoid (marijuana)-related adverse events and emergency department visits, New York City","author":"New York City Department of Health and Mental Hygiene","year":"2015"},{"issue":"1","key":"10.1016\/j.drugpo.2016.05.014_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/s40352-016-0032-z","article-title":"\u201cOn papers\u201d: Perceptions of synthetic cannabinoid use among black males under criminal justice supervision","volume":"4","author":"Richardson","year":"2016","journal-title":"Health and Justice"},{"issue":"5","key":"10.1016\/j.drugpo.2016.05.014_bib0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0960327114550886","article-title":"Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues","volume":"34","author":"Schep","year":"2015","journal-title":"Human & Experimental Toxicology"},{"issue":"2","key":"10.1016\/j.drugpo.2016.05.014_bib0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.drugpo.2016.05.014_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: Synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0080","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.drugpo.2016.05.014_bib0085","series-title":"Update: Drug-related emergency department visits involving synthetic cannabinoids","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"issue":"3","key":"10.1016\/j.drugpo.2016.05.014_bib0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"Journal of Psychopharmacology"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916301682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916301682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T13:50:17Z","timestamp":1536673817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395916301682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":18,"alternative-id":["S0955395916301682"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.05.014","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014\u20132015","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}